Ureteral obstruction as a complication of renal transplantation: a review.
Ureteral obstruction in a renal allograft, due to a variety of etiologies, is both a challenging diagnostic and therapeutic disorder. Since ureteral obstruction in a renal transplant recipient usually presents as azotemia, it must also be distinguished from acute rejection. Although ultrasound is non-invasive and readily available, the most definitive diagnostic tool is percutaneous nephrostomy tube placement with antegrade nephrostogram. A variety of therapeutic approaches are available to treat ureteral obstruction in a renal allograft. These procedures can be open (e.g., repeat ureteroneocystotomy) or utilize an endourological approach (e.g., transluminal ureteral dilatation). From an experimental standpoint, recent data in rodent models of experimental hydronephrosis demonstrate similar pathobiologic events in both the obstructed kidney and an allograft undergoing the chronic rejection process. To this end, investigation needs to be conducted to assess whether partial, unrecognized ureteral obstruction in an allograft hastens the development of chronic rejection. This would further underscore the importance of ureteral obstruction as a cause for not only acute azotemia in an allograft, but also chronic deterioration in renal transplant function.
Berger
P M
PM
Section of Urology, Milton S. Hershey Medical Center, Penn State-Geisinger Health System Hershey, Pennsylvania, USA.
Diamond
J R
JR
D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D014184:Transplantation, Homologous; D014517:Ureteral Obstruction / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy